A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Years With Recalcitrant Tinea Cruris and Corporis

NCT07312604 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Tinea Corporis
Tinea Cruris

Interventions

BIOLOGICAL: Intra-Lesional MMR Immunotherapy

Sponsor

Abeer Mohamed Abdelaziz Elkholy

Collaborators

[object Object]